Levonorgestrel, also known as the morning-after pill, is a first-line oral emergency contraceptive pill with approval from the World Health Organization to prevent pregnancy. It is FDA-approved to be used within 72 hours of unprotected sexual intercourse or when a presumed contraceptive failure has occurred. There have been cases of off-label efficacy for up to 96 hours. This activity covers levonorgestrel, including mechanism of action, pharmacology, adverse event profiles, eligible patient populations, monitoring, and highlights the role of the interprofessional team in the management of conditions where levonorgestrel therapy is helpful.

**Objectives:**
- Summarize the mechanism of action of levonorgestrel.
- Review the effective and correct administration of levonorgestrel for morning-after birth control.
- Describe the contraindications for using levonorgestrel.
- Explain the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients receiving treatment with levonorgestrel.